All filters
E-Posters
Greater Fatigue Is Associated With Worse Neurocognition in Older Persons With HIV - L. Campbell
Presented at:
International Workshop on HIV & Aging 2020
E-Posters
Neighborhood Perception and Perceived Stress Among Women With HIV - J. Bannon
Presented at:
International Workshop on HIV & Aging 2020
E-Posters
PTSD Symptoms and Hyperarousal Influenced by Childhood Trauma in Women With HIV - S. Turkson
Presented at:
International Workshop on HIV & Aging 2020
E-Posters
Association of Urinary Ceruloplasmin With Neurocognitive Impairment in HIV-1 Infection - Y. Alrajhi
Presented at:
International Workshop on HIV & Aging 2020
E-Posters
Dolutegravir (DTG) Plasma Concentrations Under Different Combinations Regimens for ART- Pre-Treated Adults Living With HIV
A. Boussairi
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Targeting Nuclear Receptors to Prevent Cobicistat Hepatotoxicity
A. Shehu
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Population Pharmacokinetic Modelling of Atazanavir in Plasma and Hair of HIV-Infected Women
L. Dickinson
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Tacrolimus and Sirolimus Doses in an HIV-Infected, Kidney-Recipient, Patient Requiring a Cobicistat-Based Antiretroviral Regimen
N. Díaz
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
The Pharmacokinetics (PK) of DOVATO (50 mg Dolutegravir (DTG)/ 300 mg Lamivudine (3TC)) Fixed-Dose Combination in HIV-Infected Patients
T. Pene Dumitrescu
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Pharmacokinetics, Safety, and Tolerability of Dolutegravir + Rilpivirine (JULUCA) in Healthy Japanese Adults
R. Mehta
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
In Utero Exposure to Antiretroviral Drugs and Pregnancy Outcomes: A Secondary Analysis of the ANRS Pharmacovigilance Database From the ANRS-Sponsored HIV Research Studies
L. Saint-lary
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Impact of the Hepatitis B Virus (HBV) Capsid Inhibitor, AB-506, on the Single Dose Pharmacokinetics (PK) of a Combined Oral Contraceptive (COC)
H. Sevinsky
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Systematic Review and Meta-Analysis of Adverse Perinatal Outcomes Associated With Prenatal Exposure to Protease Inhibitor Combination in Pregnant Women With HIV Infection
L. Saint-lary
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Evaluation of Relationships Between AB-506 Related ALT Elevations and AB-506 Pharmacokinetics (PK), Metabolite Concentrations and Plasma Bile Acids
H. Sevinsky
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Antiviral PK 2020 Abstract_6
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Antiviral PK 2020 Abstract_13A
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
E-Posters
Antiviral PK 2020 Abstract_13B
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020